US FDA refuses to approve Merck's Zetia and Vytorin medicines

The US Food and Drug Administration (FDA) has refused to approve Zetia and Vytorin, Merck's medicines that are used to reduce the risk of cardiovascular events in patients with coronary heart disease.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news